O uso de porfirinas em terapia fotodinâmica no tratamento da leishmaniose cutânea

Translated title of the contribution: The use of porphyrins in photodynamic therapy of cutaneous leishmaniasis

Mônica M. Bastos*, Núbia Boechat, Ana T.P.C. Gomes, Maria G.P.M.S. Neves, José A.S. Cavaleiro

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Leishmaniasis is a disease transmitted by protozoa of the genus Leishmania. Numerous species are responsible for the infection in humans, resulting in three clinical phenotypes. The therapeutic drug availability for treatment of this endemic disease is still limited and presents several problems. Photodynamic therapy (PDT) is presented as an alternative action for the treatment of cutaneous leishmaniasis (CL). Studies suggest that this therapy using porphyrins is relatively effective in the treatment of CL. However, data are still limited and PDT can not yet be recommended in clinical routine practice. Moreover, the mechanism of action of this promising therapy still needs to be investigated.

Translated title of the contributionThe use of porphyrins in photodynamic therapy of cutaneous leishmaniasis
Original languagePortuguese
Pages (from-to)257-267
Number of pages11
JournalRevista Virtual de Quimica
Volume4
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'The use of porphyrins in photodynamic therapy of cutaneous leishmaniasis'. Together they form a unique fingerprint.

Cite this